DTA Team

Andy Molnar

Chief Executive Officer, Digital Therapeutics Alliance

Andy Molnar is the CEO of the Digital Therapeutics Alliance, a trade organization focused on the needs of the clinically validated digital therapeutics industry. Andy has spent the last 3.5 years focusing on how to commercialize software as a medical device (SaMD) products, most recently as Vice President of Market Access and Government Affairs at Cognoa and Sr. Director of Market Access and Payer Data Strategy at Pear Therapeutics. Andy spent most of his time working on generating meaningful evidence for payers, commercial planning, and working with various government agencies and trade organizations to update policy for reimbursement.

Copyright © 2022 Digital Therapeutics Alliance™